Edward P Lawrence
Insider
First SEC filing: Sept. 19, 2007 · Latest: Feb. 14, 2008
Institution
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| July 28, 2017 | IVZ | A | 474 | · | · | 37,320 Direct | +1.29% | Acquired | (price as of 2026-10-02) |
| April 28, 2017 | IVZ | A | 1,100 | · | · | 36,846 Direct | +3.08% | Acquired | (price as of 2026-10-02) |
| Jan. 27, 2017 | IVZ | A | 1,228 | · | · | 35,746 Direct | +3.56% | Acquired | (price as of 2026-10-02) |
| Dec. 13, 2016 | IVZ | G | 600 | · | · | 34,518 Direct | -1.71% | Disposed | (price as of 2026-10-02) |
| Oct. 28, 2016 | IVZ | A | 1,270 | · | · | 35,118 Direct | +3.75% | Acquired | (price as of 2026-10-02) |
| Sept. 9, 2016 | IVZ | S | 1,609 | $30.84 | $49,622 | 33,848 Direct | -4.54% | Disposed | -0.6% (price as of 2026-10-02) |
| July 29, 2016 | IVZ | A | 1,242 | · | · | 35,457 Direct | +3.63% | Acquired | (price as of 2026-10-02) |
| April 29, 2016 | IVZ | A | 1,168 | · | · | 34,215 Direct | +3.53% | Acquired | (price as of 2026-10-02) |
| Jan. 29, 2016 | IVZ | A | 1,211 | · | · | 33,047 Direct | +3.80% | Acquired | (price as of 2026-10-02) |
| Dec. 9, 2015 | IVZ | G | 600 | · | · | 31,836 Direct | -1.85% | Disposed | (price as of 2026-10-02) |
| Oct. 30, 2015 | IVZ | A | 1,092 | · | · | 32,436 Direct | +3.48% | Acquired | (price as of 2026-10-02) |
| July 31, 2015 | IVZ | A | 939 | · | · | 31,344 Direct | +3.09% | Acquired | (price as of 2026-10-02) |
| May 27, 2015 | IVZ | S | 2,500 | $40.32 | $100,800 | 30,405 Direct | -7.60% | Disposed | -24.0% (price as of 2026-10-02) |
| May 1, 2015 | IVZ | A | 871 | · | · | 32,905 Direct | +2.72% | Acquired | (price as of 2026-10-02) |
| Jan. 30, 2015 | IVZ | A | 986 | · | · | 32,034 Direct | +3.18% | Acquired | (price as of 2026-10-02) |
| Dec. 4, 2014 | IVZ | G | 500 | · | · | 31,048 Direct | -1.58% | Disposed | (price as of 2026-10-02) |
| Dec. 4, 2014 | IVZ | S | 895 | $40.37 | $36,131 | 31,548 Direct | -2.76% | Disposed | -24.1% (price as of 2026-10-02) |
| Oct. 31, 2014 | IVZ | A | 895 | · | · | 32,443 Direct | +2.84% | Acquired | (price as of 2026-10-02) |
| Aug. 1, 2014 | IVZ | A | 958 | · | · | 31,548 Direct | +3.13% | Acquired | (price as of 2026-10-02) |
| May 2, 2014 | IVZ | A | 1,008 | · | · | 30,590 Direct | +3.41% | Acquired | (price as of 2026-10-02) |
| Jan. 31, 2014 | IVZ | A | 714 | · | · | 29,582 Direct | +2.47% | Acquired | (price as of 2026-10-02) |
| Nov. 1, 2013 | IVZ | A | 701 | · | · | 28,868 Direct | +2.49% | Acquired | (price as of 2026-10-02) |
| Aug. 1, 2013 | IVZ | A | 718 | · | · | 28,167 Direct | +2.62% | Acquired | (price as of 2026-10-02) |
| June 11, 2013 | IVZ | G | 600 | · | · | 27,449 Direct | -2.14% | Disposed | (price as of 2026-10-02) |
| May 1, 2013 | IVZ | A | 755 | · | · | 28,049 Direct | +2.77% | Acquired | (price as of 2026-10-02) |
| Feb. 1, 2013 | IVZ | A | 855 | · | · | 27,294 Direct | +3.23% | Acquired | (price as of 2026-10-02) |
| Nov. 2, 2012 | IVZ | A | 973 | · | · | 26,439 Direct | +3.82% | Acquired | (price as of 2026-10-02) |
| July 27, 2012 | IVZ | A | 1,073 | · | · | 25,466 Direct | +4.40% | Acquired | (price as of 2026-10-02) |
| April 27, 2012 | IVZ | A | 946 | · | · | 24,393 Direct | +4.03% | Acquired | (price as of 2026-10-02) |
| Jan. 27, 2012 | IVZ | A | 1,033 | · | · | 23,447 Direct | +4.61% | Acquired | (price as of 2026-10-02) |
| Oct. 25, 2011 | IVZ | A | 1,263 | · | · | 22,414 Direct | +5.97% | Acquired | (price as of 2026-10-02) |
| July 27, 2011 | IVZ | A | 1,066 | · | · | 21,151 Direct | +5.31% | Acquired | (price as of 2026-10-02) |
| April 28, 2011 | IVZ | A | 951 | · | · | 20,085 Direct | +4.97% | Acquired | (price as of 2026-10-02) |
| Jan. 28, 2011 | IVZ | A | 963 | · | · | 19,134 Direct | +5.30% | Acquired | (price as of 2026-10-02) |
| Oct. 26, 2010 | IVZ | A | 1,062 | · | · | 18,171 Direct | +6.21% | Acquired | (price as of 2026-10-02) |
| July 28, 2010 | IVZ | A | 1,228 | · | · | 17,109 Direct | +7.73% | Acquired | (price as of 2026-10-02) |
| April 29, 2010 | IVZ | A | 1,003 | · | · | 15,881 Direct | +6.74% | Acquired | (price as of 2026-10-02) |
| Jan. 29, 2010 | IVZ | A | 906 | · | · | 14,878 Direct | +6.48% | Acquired | (price as of 2026-10-02) |
| Oct. 21, 2009 | IVZ | A | 767 | · | · | 13,972 Direct | +5.81% | Acquired | (price as of 2026-10-02) |
| July 28, 2009 | IVZ | A | 916 | · | · | 13,205 Direct | +7.45% | Acquired | (price as of 2026-10-02) |
| April 24, 2009 | IVZ | A | 1,192 | · | · | 12,289 Direct | +10.74% | Acquired | (price as of 2026-10-02) |
| Feb. 2, 2009 | IVZ | A | 1,401 | · | · | 11,097 Direct | +14.45% | Acquired | (price as of 2026-10-02) |
| Oct. 30, 2008 | IVZ | A | 1,217 | · | · | 9,696 Direct | +14.35% | Acquired | (price as of 2026-10-02) |
| July 25, 2008 | IVZ | A | 787 | · | · | 8,479 Direct | +10.23% | Acquired | (price as of 2026-10-02) |
| July 16, 2008 | IVZ | S | 2,500 | $20.34 | $50,850 | 7,692 Direct | -24.53% | Disposed | 50.7% (price as of 2026-10-02) |
| May 16, 2008 | IVZ | A | 714 | · | · | 10,192 Direct | +7.53% | Acquired | (price as of 2026-10-02) |
| Feb. 20, 2008 | IVZ | A | 1,593 | · | · | 9,478 Direct | +20.20% | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Initial ownership (Form 3) 3 holdings
Securities held when first becoming an insider, per SEC Form 3.